Branchio-oto-renal syndrome: Identification of novel mutations, molecular characterization, mutation distribution, and prospects for genetic testing

Shrawan Kumar, Karen Deffenbacher, Cor W.R.J. Cremers, Guy Van Camp, William J. Kimberling

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

The branchio-oto-renal syndrome (BOR) is an autosomal dominant disorder characterized by branchial clefts, preauricular sinuses, hearing loss, and renal anomalies. The BOR gene, EYA1, on chromosome 8q13 has recently been cloned and mutations have been identified. In this study, we have analyzed the sites of mutations in the EYA1 gene in BOR patients to determine the spectrum of mutations. We have identified two missense mutations and have compared all the mutations reported to date in the EYA1 gene. In total, 20 mutations have been described, the majority of which are clustered in the carboxy-terminal region of the gene. The clinical features of the BOR individuals have also been compared to determine if the nature of the mutation correlates with the type and severity of the clinical symptoms. Most of the mutations arose de novo and, other than the clustering in carboxy-terminal exons 9-16, no mutation hot spots have been identified. These results provide the basis for molecular genetic testing that will help in the clinical evaluation and genetic counseling of members of BOR families.

Original languageEnglish (US)
Pages (from-to)243-251
Number of pages9
JournalGenetic Testing
Volume1
Issue number4
StatePublished - Dec 1 1998

Fingerprint

Branchio-Oto-Renal Syndrome
Genetic Testing
Mutation
Genes
Branchial Region
Genetic Counseling
Missense Mutation
Hearing Loss
Cluster Analysis
Molecular Biology
Exons
Chromosomes

ASJC Scopus subject areas

  • Genetics(clinical)

Cite this

Kumar, S., Deffenbacher, K., Cremers, C. W. R. J., Van Camp, G., & Kimberling, W. J. (1998). Branchio-oto-renal syndrome: Identification of novel mutations, molecular characterization, mutation distribution, and prospects for genetic testing. Genetic Testing, 1(4), 243-251.

Branchio-oto-renal syndrome : Identification of novel mutations, molecular characterization, mutation distribution, and prospects for genetic testing. / Kumar, Shrawan; Deffenbacher, Karen; Cremers, Cor W.R.J.; Van Camp, Guy; Kimberling, William J.

In: Genetic Testing, Vol. 1, No. 4, 01.12.1998, p. 243-251.

Research output: Contribution to journalArticle

Kumar, S, Deffenbacher, K, Cremers, CWRJ, Van Camp, G & Kimberling, WJ 1998, 'Branchio-oto-renal syndrome: Identification of novel mutations, molecular characterization, mutation distribution, and prospects for genetic testing', Genetic Testing, vol. 1, no. 4, pp. 243-251.
Kumar, Shrawan ; Deffenbacher, Karen ; Cremers, Cor W.R.J. ; Van Camp, Guy ; Kimberling, William J. / Branchio-oto-renal syndrome : Identification of novel mutations, molecular characterization, mutation distribution, and prospects for genetic testing. In: Genetic Testing. 1998 ; Vol. 1, No. 4. pp. 243-251.
@article{3d4892496e7844f6a6a08c73ca46ac19,
title = "Branchio-oto-renal syndrome: Identification of novel mutations, molecular characterization, mutation distribution, and prospects for genetic testing",
abstract = "The branchio-oto-renal syndrome (BOR) is an autosomal dominant disorder characterized by branchial clefts, preauricular sinuses, hearing loss, and renal anomalies. The BOR gene, EYA1, on chromosome 8q13 has recently been cloned and mutations have been identified. In this study, we have analyzed the sites of mutations in the EYA1 gene in BOR patients to determine the spectrum of mutations. We have identified two missense mutations and have compared all the mutations reported to date in the EYA1 gene. In total, 20 mutations have been described, the majority of which are clustered in the carboxy-terminal region of the gene. The clinical features of the BOR individuals have also been compared to determine if the nature of the mutation correlates with the type and severity of the clinical symptoms. Most of the mutations arose de novo and, other than the clustering in carboxy-terminal exons 9-16, no mutation hot spots have been identified. These results provide the basis for molecular genetic testing that will help in the clinical evaluation and genetic counseling of members of BOR families.",
author = "Shrawan Kumar and Karen Deffenbacher and Cremers, {Cor W.R.J.} and {Van Camp}, Guy and Kimberling, {William J.}",
year = "1998",
month = "12",
day = "1",
language = "English (US)",
volume = "1",
pages = "243--251",
journal = "Genetic Testing and Molecular Biomarkers",
issn = "1945-0265",
publisher = "Mary Ann Liebert Inc.",
number = "4",

}

TY - JOUR

T1 - Branchio-oto-renal syndrome

T2 - Identification of novel mutations, molecular characterization, mutation distribution, and prospects for genetic testing

AU - Kumar, Shrawan

AU - Deffenbacher, Karen

AU - Cremers, Cor W.R.J.

AU - Van Camp, Guy

AU - Kimberling, William J.

PY - 1998/12/1

Y1 - 1998/12/1

N2 - The branchio-oto-renal syndrome (BOR) is an autosomal dominant disorder characterized by branchial clefts, preauricular sinuses, hearing loss, and renal anomalies. The BOR gene, EYA1, on chromosome 8q13 has recently been cloned and mutations have been identified. In this study, we have analyzed the sites of mutations in the EYA1 gene in BOR patients to determine the spectrum of mutations. We have identified two missense mutations and have compared all the mutations reported to date in the EYA1 gene. In total, 20 mutations have been described, the majority of which are clustered in the carboxy-terminal region of the gene. The clinical features of the BOR individuals have also been compared to determine if the nature of the mutation correlates with the type and severity of the clinical symptoms. Most of the mutations arose de novo and, other than the clustering in carboxy-terminal exons 9-16, no mutation hot spots have been identified. These results provide the basis for molecular genetic testing that will help in the clinical evaluation and genetic counseling of members of BOR families.

AB - The branchio-oto-renal syndrome (BOR) is an autosomal dominant disorder characterized by branchial clefts, preauricular sinuses, hearing loss, and renal anomalies. The BOR gene, EYA1, on chromosome 8q13 has recently been cloned and mutations have been identified. In this study, we have analyzed the sites of mutations in the EYA1 gene in BOR patients to determine the spectrum of mutations. We have identified two missense mutations and have compared all the mutations reported to date in the EYA1 gene. In total, 20 mutations have been described, the majority of which are clustered in the carboxy-terminal region of the gene. The clinical features of the BOR individuals have also been compared to determine if the nature of the mutation correlates with the type and severity of the clinical symptoms. Most of the mutations arose de novo and, other than the clustering in carboxy-terminal exons 9-16, no mutation hot spots have been identified. These results provide the basis for molecular genetic testing that will help in the clinical evaluation and genetic counseling of members of BOR families.

UR - http://www.scopus.com/inward/record.url?scp=0000203969&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0000203969&partnerID=8YFLogxK

M3 - Article

C2 - 10464653

AN - SCOPUS:0000203969

VL - 1

SP - 243

EP - 251

JO - Genetic Testing and Molecular Biomarkers

JF - Genetic Testing and Molecular Biomarkers

SN - 1945-0265

IS - 4

ER -